• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    The Cigna Group filed SEC Form 8-K: Leadership Update

    6/20/24 4:15:30 PM ET
    $CI
    Medical Specialities
    Health Care
    Get the next $CI alert in real time by email
    The Cigna Group Form 8-K
    false 0001739940 0001739940 2024-06-14 2024-06-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

     

    SECURITIES AND EXCHANGE COMMISSION

     

    Washington, D.C. 20549

     

    FORM 8-K

     

     

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of the

     

    Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported) June 14, 2024

     

    The Cigna Group

     

    (Exact name of registrant as specified in its charter)

     

    Delaware

    (State or other jurisdiction of

    incorporation)

    001-38769

    (Commission File Number)

    82-4991898

    (IRS Employer

    Identification No.)

     

     

    900 Cottage Grove Road

    Bloomfield, Connecticut 06002

     

    (Address of principal executive offices) (Zip Code)

     

    Registrant’s telephone number, including area code:

     

    (860) 226-6000

     

    Not Applicable

     

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading Symbol(s) Name of each exchange on which registered
    Common Stock, Par Value $0.01 CI New York Stock Exchange, Inc.

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     
     

     

     

     

    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     

    On June 14, 2024, The Cigna Group (the “Company” or “our”) appointed Jamie Kates as the Company’s Chief Accounting Officer, serving as the Company’s principal accounting officer, effective July 1, 2024.

    Ms. Kates, 44, has served as Vice President, Accounting, since October 2021, pursuant to which she managed the Evernorth Health Services accounting, compliance and consolidation functions. Prior to that, she served as Managing Director, Accounting, from January 2019 through October 2021, during which she managed the Evernorth Health Services accounting and compliance functions. Ms. Kates joined The Cigna Group in 2009 and has held roles of increasing responsibility during her tenure. Ms. Kates is a Certified Public Accountant.

    In connection with her appointment, Ms. Kates accepted an offer letter, pursuant to which she will receive an annual base salary of $400,000. Her 2024 Enterprise Incentive Plan Annual Target will be 50% of her annual base salary (prorated for time in role) and her 2025 Long-Term Incentive Target will be $300,000. Ms. Kates will also be eligible to participate in the Company’s employee benefit plans, in accordance with their terms.

     

     

     
     

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      THE CIGNA GROUP
       
    Date:  June 20, 2024 By: /s/ Brian C. Evanko       
        Brian C. Evanko
        Executive Vice President, Chief Financial Officer, The Cigna Group, and President and Chief Executive Officer, Cigna Healthcare

      

    Get the next $CI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CI

    DatePrice TargetRatingAnalyst
    2/6/2025$323.00Outperform → Mkt Perform
    Bernstein
    6/26/2024$400.00Overweight
    Piper Sandler
    5/30/2024$388.00Outperform
    Robert W. Baird
    3/6/2024$393.00Overweight
    Barclays
    2/5/2024$334.00 → $372.00Neutral → Overweight
    Cantor Fitzgerald
    2/5/2024$327.00 → $354.00Sector Perform → Outperform
    RBC Capital Mkts
    2/1/2024$355.00 → $370.00Hold → Buy
    Deutsche Bank
    1/4/2024$330.00 → $372.00Mkt Perform → Outperform
    Bernstein
    More analyst ratings

    $CI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Hennigan Michael J was granted 568 shares (SEC Form 4)

      4 - Cigna Group (0001739940) (Issuer)

      6/4/25 4:58:29 PM ET
      $CI
      Medical Specialities
      Health Care
    • SEC Form 3 filed by new insider Hennigan Michael J

      3 - Cigna Group (0001739940) (Issuer)

      6/3/25 5:04:45 PM ET
      $CI
      Medical Specialities
      Health Care
    • SEC Form 4 filed by Director Kurian George

      4 - Cigna Group (0001739940) (Issuer)

      6/3/25 5:04:40 PM ET
      $CI
      Medical Specialities
      Health Care

    $CI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • The Cigna Group Health Equity Impact Fund Opens 2025 Grants

      The Fund will distribute another $3 million to nonprofits to improve health outcomes BLOOMFIELD, Conn., June 4, 2025 /PRNewswire/ -- The Cigna Group Foundation today announced the second year of grants from its Health Equity Impact Fund. The initiative will allocate a total of $3 million to two cities: Hartford, Conn., where it began last year, and St. Louis, Mo., which struggles with significant health disparities among its adult residents. "Creating healthier communities starts with supporting healthy habits and improving equitable access to care," said Melissa Skottegaard,

      6/4/25 6:00:00 AM ET
      $CI
      Medical Specialities
      Health Care
    • The Cigna Group Announces Appointment of Michael J. Hennigan to Board of Directors

      BLOOMFIELD, Conn., June 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Michael J. Hennigan has been appointed to the organization's Board of Directors. His appointment is effective June 2. Mr. Hennigan is the Executive Chairman of Marathon Petroleum Corporation (MPC), an integrated downstream energy company, and MPLX, a diversified master limited partnership formed by MPC. He joined the company in 2017 and previously held the roles of Chief Executive Officer of MPC and Chairman, President and Chief Executive Officer of MPLX. Prior

      6/2/25 4:30:00 PM ET
      $CI
      Medical Specialities
      Health Care
    • Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month

      Patients can save as much as $3600 per year versus direct-to-consumer manufacturer programs, and out of pocket cost applies to their annual deductibleNew offering helps employers meet growing demand for FDA-approved weight loss medications at a lower net cost per prescription while ensuring clinical safety for patientsST LOUIS, May 21, 2025  /PRNewswire/ -- Evernorth, the health services division of The Cigna Group (NYSE:CI) announced a first-of-its-kind pharmacy benefit offering that make weight loss medications WEGOVY® and ZEPBOUND® more available to patients. Through direct negotiations with the medications' manufacturers, Evernorth has ensured that patients' monthly cost will not exceed

      5/21/25 4:30:00 PM ET
      $CI
      Medical Specialities
      Health Care

    $CI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by The Cigna Group

      SC 13G - Cigna Group (0001739940) (Subject)

      11/12/24 9:55:14 AM ET
      $CI
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by The Cigna Group (Amendment)

      SC 13G/A - Cigna Group (0001739940) (Subject)

      2/13/24 5:02:29 PM ET
      $CI
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by The Cigna Group (Amendment)

      SC 13G/A - Cigna Group (0001739940) (Subject)

      2/9/24 8:50:20 AM ET
      $CI
      Medical Specialities
      Health Care

    $CI
    SEC Filings

    See more
    • The Cigna Group filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - Cigna Group (0001739940) (Filer)

      6/2/25 5:03:47 PM ET
      $CI
      Medical Specialities
      Health Care
    • The Cigna Group filed SEC Form 8-K: Regulation FD Disclosure

      8-K - Cigna Group (0001739940) (Filer)

      5/20/25 6:01:22 AM ET
      $CI
      Medical Specialities
      Health Care
    • SEC Form 144 filed by The Cigna Group

      144 - Cigna Group (0001739940) (Subject)

      5/9/25 4:27:05 PM ET
      $CI
      Medical Specialities
      Health Care

    $CI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • The Cigna Group downgraded by Bernstein with a new price target

      Bernstein downgraded The Cigna Group from Outperform to Mkt Perform and set a new price target of $323.00

      2/6/25 7:05:01 AM ET
      $CI
      Medical Specialities
      Health Care
    • Piper Sandler initiated coverage on The Cigna Group with a new price target

      Piper Sandler initiated coverage of The Cigna Group with a rating of Overweight and set a new price target of $400.00

      6/26/24 7:28:18 AM ET
      $CI
      Medical Specialities
      Health Care
    • Robert W. Baird initiated coverage on The Cigna Group with a new price target

      Robert W. Baird initiated coverage of The Cigna Group with a rating of Outperform and set a new price target of $388.00

      5/30/24 7:35:19 AM ET
      $CI
      Medical Specialities
      Health Care

    $CI
    Leadership Updates

    Live Leadership Updates

    See more

    $CI
    Financials

    Live finance-specific insights

    See more
    • The Cigna Group Announces Appointment of Michael J. Hennigan to Board of Directors

      BLOOMFIELD, Conn., June 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Michael J. Hennigan has been appointed to the organization's Board of Directors. His appointment is effective June 2. Mr. Hennigan is the Executive Chairman of Marathon Petroleum Corporation (MPC), an integrated downstream energy company, and MPLX, a diversified master limited partnership formed by MPC. He joined the company in 2017 and previously held the roles of Chief Executive Officer of MPC and Chairman, President and Chief Executive Officer of MPLX. Prior

      6/2/25 4:30:00 PM ET
      $CI
      Medical Specialities
      Health Care
    • The Cigna Group's "Community Vitality Project" Donates $75,000 to Nonprofits through Program Encouraging Fitness and Community Engagement

      As part of the company's initiative, thousands of employees logged 280,000 minutes of exercise over nine days Cigna leaders biked to Hartford, Conn.'s Dunkin' Park to host Boys & Girls Clubs members for a Yard Goats baseball game, with surprise appearances by UConn basketball coach and playersBLOOMFIELD, Conn., Sept. 9, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI) put out a challenge to its workforce this summer, inviting colleagues to join its first-ever Community Vitality Project, a nine-day challenge combining fun, fitness and fundraising. By logging more than 280,000 minutes of fitness activities and awarding their minutes spent moving, The Cigna Group employees helped determine how to

      9/9/24 7:00:00 AM ET
      $CI
      Medical Specialities
      Health Care
    • The Cigna Group announces leadership changes to continue driving growth

      Brian Evanko to continue as Chief Financial Officer, will serve as new President and CEO of Cigna HealthcareAnn Dennison to join The Cigna Group as Deputy Chief Financial OfficerMike Triplett to retire by end of 2024 and Bryan Holgerson promoted to President of U.S. Commercial for Cigna HealthcareEric Palmer to assume expanded role leading enterprise strategy and corporate development, will continue as President and CEO of Evernorth Health ServicesBLOOMFIELD, Conn., Jan. 17, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today announced leadership changes designed to continue accelerating growth across Evernorth Health Services and Cigna Healthcare.

      1/17/24 9:15:00 AM ET
      $CI
      Medical Specialities
      Health Care
    • The Cigna Group Reports Strong First Quarter 2025 Results, Raises 2025 Outlook

      Total revenues for the first quarter 2025 increased 14% to $65.5 billionShareholders' net income for the first quarter 2025 was $1.3 billion, or $4.85 per shareAdjusted income from operations1 for the first quarter 2025 was $1.8 billion, or $6.74 per share2025 adjusted income from operations1,2 increased to at least $29.60 per share2BLOOMFIELD, Conn., May 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported strong first quarter 2025 results, reflecting growth and focused execution across its diversified portfolio of businesses. "We are buildin

      5/2/25 6:00:00 AM ET
      $CI
      Medical Specialities
      Health Care
    • The Cigna Group Declares Quarterly Dividend

      BLOOMFIELD, Conn., April 23, 2025 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE:CI) today declared a cash dividend of $1.51 per share of its common stock, payable on June 18, 2025 to shareholders of record as of the close of business on June 3, 2025. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services m

      4/23/25 4:30:00 PM ET
      $CI
      Medical Specialities
      Health Care
    • AM Best Affirms Credit Ratings of The Cigna Group and Its Subsidiaries

      AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of "a+" (Excellent) of the key U.S. life/health subsidiaries and Europe-based insurance companies of The Cigna Group (Cigna) (headquartered in Bloomfield, CT) (NYSE:CI). In addition, AM Best has affirmed the Long-Term ICR of "bbb+" (Good) and the Long-Term Issue Credit Ratings (Long-Term IRs) of Cigna. AM Best also has affirmed the Short-Term Issue Credit Rating (Short-Term IR) of Cigna. The outlook of these Credit Ratings (ratings) is stable. (Please see below for a detailed listing of the companies and ratings.) The majority of Cigna's core U.S. health insuran

      4/8/25 5:46:00 PM ET
      $CI
      Medical Specialities
      Health Care